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Abstract: In humans, sexual dimorphism is associated
with the presence of two X chromosomes in the female,
whereas males possess only one X and a small and largely
degenerate Y chromosome. How do men cope with
having only a single X chromosome given that virtually all
other chromosomal monosomies are lethal? Ironically, or
even typically many might say, women and more
generally female mammals contribute most to the job
by shutting down one of their two X chromosomes at
random. This phenomenon, called X-inactivation, was
originally described some 50 years ago by Mary Lyon and
has captivated an increasing number of scientists ever
since. The fascination arose in part from the realisation
that the inactive X corresponded to a dense heterochro-
matin mass called the ‘‘Barr body’’ whose number varied
with the number of Xs within the nucleus and from the
many intellectual questions that this raised: How does
the cell count the X chromosomes in the nucleus and
inactivate all Xs except one? What kind of molecular
mechanisms are able to trigger such a profound,
chromosome-wide metamorphosis? When is X-inactiva-
tion initiated? How is it transmitted to daughter cells and
how is it reset during gametogenesis? This review retraces
some of the crucial findings, which have led to our current
understanding of a biological process that was initially
considered as an exception completely distinct from
conventional regulatory systems but is now viewed as a
paradigm ‘‘par excellence’’ for epigenetic regulation.
A History of X-Inactivation: Early Studies
(1950–1980)
The 1950s and the decades that followed provided much of the
basis for present-day developmental biology and molecular
genetics (Figure 1). It was a period of crucial advances in
mammalian embryology (e.g., ex vivo growth of mouse embryos
[1,2] and transgenic experiments [3]). Contemporary description
of the DNA double-helix [4], of homologous recombination [5], of
cloning [6], and of the first DNA-based genetic markers [7]
similarly opened up the path for genetic engineering, extensive
genetic mapping, and seemingly extraordinary quirky observa-
tions such as those concerning Position Effect Variation (PEV) in
Drosophila [8,9]. McClintock’s earlier work on transposable
elements in maize [10] could, moreover, increasingly be
assimilated and interpreted with reference to the intellectual
context provided by work such as Jacob and Monod’s on the
genetic regulation of the lac operon [11]. The new and seemingly
quirky kinds of gene regulation that could not be explained by
Mendelian genetics per se laid the groundwork for the concept of
epigenetics—a term derived from the fusion of ‘‘genetics’’,
referring to the primary DNA code, and ‘‘epigenesis’’, referring
to the differential interpretation of the hereditary material within
different cell lineages—as being, at least in part, responsible for the
relationship between genes and phenotypes [12].
The conditions and nature of the discovery of X-inactivation in
the early 1960s illustrate perfectly both the intellectual burgeoning
that characterised these years and the emergence of the concept of
epigenetics.
The Discovery of X-Inactivation
In 1949, the scrutiny of motoneurons of a female calico cat by
Barr and his PhD student Bertram led to the identification of a
dark, condensed structure situated close to the nucleolus [13].
Whilst Barr and Bertram did not realise at the time that they were
looking at an inactive X chromosome (Xi)—the critical link
between the ‘‘Barr’’ body and a condensed X chromosome was to
be made only later by Susumu Ohno [14,15]—their observation,
along with that relating to the description of two X-linked loci,
Tabby and Mottled, able to confer a mosaic coat colour to
heterozygous females [16], and the realisation in 1959 that XO
female mice were able both to develop normally and to reproduce
[17], were critical to the formulation by Mary Lyon of the X-
inactivation theory (for early reviews relating to the discovery of
X-inactivation, see [18–20]).
In her key 1961 publication, Mary Lyon suggested that the
heterochromatic X could correspond in different somatic cells of
the same female mammal either to the maternally inherited or to
the paternally inherited X chromosome, and proposed that a
process leading to the global silencing of the genes of an entire X
chromosome referred to as ‘‘X-inactivation’’ occurred during early
embryogenesis and was clonally inherited thereafter, thus
providing an explanation for the tortoiseshell pattern of Barr’s
calico cat [21]. Similar ideas were also advanced by Beutler and
colleagues to account for their observation of the presence of two
types of red cell in human females heterozygous for the X-linked
deficiency in glucose-6-phosphate dehydrogenase (G6pdx gene)
[22] and by Russell, who put forward a similar—if less elaborate—
Citation: Morey C, Avner P (2011) The Demoiselle of X-Inactivation: 50 Years Old
and As Trendy and Mesmerising As Ever. PLoS Genet 7(7): e1002212. doi:10.1371/
journal.pgen.1002212
Editor: Wendy A. Bickmore, Medical Research Council Human Genetics Unit,
United Kingdom
Published July 21, 2011
Copyright:  2011 Morey, Avner. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Funding: CM and PA were supported by recurrent funding from the Institute
Pasteur and the CNRS and by grants from the ANR. The funders had no role in the
preparation of this article.
Competing Interests: The authors have declared that no competing interests
exist.
* E-mail: cmorey@pasteur.fr
PLoS Genetics | www.plosgenetics.org 1 July 2011 | Volume 7 | Issue 7 | e1002212explanation for variegation in female mice carrying X-autosome
translocations [23].
Counting, Choosing, and Skewing
Mary Lyon’s theory prompted researchers to study individuals
carrying more than one X per set of autosomes. Surprisingly,
independently of the configuration, all but one of the X
chromosomes in the cell were observed to be condensed,
suggesting that each cell could ‘‘count’’ the number of X
chromosomes and accordingly inactivate (n21) Xs per autosome
set [20]. This presumed counting process would therefore be
responsible for the absence of X-inactivation in male cells.
Other surprising observations concerned the concept of
‘‘choice’’ of active and inactive X(s) and the molecular
mechanisms ensuring randomness. Non-randomness, or skewing,
can be caused by secondary selection for or against cells carrying
the active or the inactive X chromosome (for review see [24]) or
alternatively by primary non-random choice occurring during the
X-inactivation process itself. The latter implies that a distortion
from the 1:1 ratio of X-inactivation in diploid cells can be caused
by factors/genomic region(s) implicated in the X-inactivation
process itself. An example of primary skewing is the X-controlling
element (Xce), a mouse locus defined in 1972 by Bruce Cattanach,
after crosses of mice on different genetic backgrounds revealed that
some Xs were more likely to resist X-inactivation than others
depending on the Xce allele they carried [25]. No locus
homologous to Xce has as yet been described in the human,
possibly due to the difficulties of conducting similar analyses.
Developmental Regulation of X-Inactivation
Another key issue at this time was the establishment of where
and when X-inactivation took place during development. In the
mouse, the Xs that originate either from spermatogenesis, where
the paternal X is sequestered within the ‘‘sex body’’ (for review see
[26]), or from the female germline, where the maternal X
undergoes reactivation at the onset of meiosis, were both shown to
be active in the fertilised egg and to remain active until the 8-cell
stage as measured by biochemical studies of the few available X-
linked isoenzymes [27,28]. Such early biallelic expression was
suspected to concern only a few genes and/or to be of low level
and therefore tolerated at these early embryonic stages. The first
wave of X-inactivation was originally thought to occur around
E3.5 in the extra-embryonic tissues of the trophectoderm and of
the primitive endoderm and to consist in a preferential inactivation
of the paternal X (imprinted X-inactivation) [29]. In contrast,
random X-inactivation was identified as occurring around the
time of implantation (E5.5) in cells of the epiblast that give rise to
the embryo proper [30,31]. Of note, the description of imprinting
as part of the X-inactivation anticipated by several years the first
reports of parental imprinting at autosomal loci [32,33].
These early studies resulted in X-inactivation being firmly
established as the major mechanism responsible for dosage
compensation of X-linked gene expression between the sexes in
mammals, with the characterisation of a small number of key
characteristics such as late replication timing and condensed
heterochromatic structure allowing the Xi to be reproducibly
distinguished from its active homologue.
The X-Inactivation Centre and the Xist/XIST Gene
(1970–2000)
Intuitively, both counting and choice had to require elaborate
mechanisms of a new kind involving both the trans communication
between Xs and between X chromosomes and autosomes and the
Figure 1. Timeline showing milestones in the history of X-inactivation (1950–1975). Images are taken from http://commons.wikimedia.
org, are a courtesy of the corresponding authors, or are unpublished data.
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chromosome. Both functions were postulated to be controlled by a
single X-linked region called the X-Inactivation Centre (Xic/XIC
in mouse/human) from which the X-inactivation signal would
then spread to the rest of the chromosome [34]. Retrospectively, it
appears relatively visionary to have imagined such a region
capable of chromosome-wide concerted gene silencing, especially
considering that long-range cis-regulations such as the b-globin
Locus Control Region were reported only considerably later
[35,36]. Paradoxically, the trans effect, which now seems
particularly intriguing, may have appeared, at the time, as
something relatively common given the fact that transvection in
Drosophila had been described by Ed Lewis some 29 years earlier
[37] (Figure 2; for review, see [38]).
Defining the X-Inactivation Centre (Xic/XIC) Using
Chromosome Rearrangements and Transgenesis
The hunt for the Xic/XIC was initially engaged in the human by
comparing a battery of X-autosome translocations that had been
identified in clinical research centres. Translocation breakpoints
were determined cytologically using chromosome banding pat-
terns and X-inactivation profiles were assessed through replication
timing. These experiments resulted in the human XIC candidate
region being restricted to an interval of some 660–1,200 kb [39].
Similar approaches led to a much larger genetic interval of 8 CM
being defined in the mouse [40,41]. Importantly, both series of
studies confirmed the original hypothesis that a single X-linked
region—and not several interspersed loci—underlay Xic/XIC
function. Other experiments using mouse translocations showed
that inactivation was able to spread from the Xi into attached
autosomal material, indicating that the propagation of X-
inactivation probably involved mechanisms similar to PEV in
Drosophila rather than mechanisms depending exclusively on X-
specific sequences [42].
Early observations on female Embryonal Carcinoma (EC) cells
[43] that had suggested that such cell lines might prove useful for
X-inactivation studies [44] were confirmed and amplified by the
derivation of male and female Embryonic Stem (ES) cells, which
were shown to recapitulate, upon ex vivo differentiation, the steps
leading to stable random X-inactivation. The concomitant
development of large fragment transgenesis using these ES cells
and embryos permitted the pursuit of Xic/XIC function using
Yeast Artificial Chromosomes (YACs) first, then P1 phages and
cosmids carrying different Xic formats [45–48]. These studies
allowed the minimal Xic region necessary for both random X-
inactivation and imprinted X-inactivation to be defined [45,49].
An experimental rider to the 450-kb region defined as necessary
for random X-inactivation is the multicopy nature of the transgene
array used [50] (for review see [51]).
The Xist/XIST Non-Coding Gene
The search for an XIC candidate gene led to the isolation of the
XIST gene based on its specific expression from the human Xi
(hence its name, X-inactive specific transcripts) [52]. Though the
human and mouse Xist homologues are relatively poorly conserved
at the sequence level, both lie within the XIC/Xic and show similar
overall genomic organisation [53–56]. Both XIST/Xist genes
produced very large transcripts (15–17 kb) restricted to the nucleus
that do not code for a protein. In this respect, Xist/XIST
constituted one of the first large non-coding RNAs to be
discovered, not long after the H19 RNA involved in the regulation
of the imprinted locus Igf2/H19 was described [57].
The need to follow the behaviour of the inactive and active X
chromosomes within the context of a single nucleus led to the
rapid implementation of single cell analyses such as fluorescence in
situ hybridisation (FISH) techniques. This allowed the visualisation
of XIST RNAs within female somatic nuclei as an accumulation or
decoration of the Xi, suggesting a possible structural role for the
Xist/XIST transcripts [54,58]. Additionally, kinetics of Xist
expression during early mouse development revealed that Xist
was expressed as early as the 4-cell stage from the paternal X,
suggesting early onset of imprinted X-inactivation in the embryo
[59,60]. The lack of inactivation of an X chromosome mutated for
Xist confirmed the major role of the gene in X-inactivation
initiation [61,62].
Xist/XIST Does Not Resume All Xic/XIC Functions
During this period, major positional cloning efforts using genetic
and physical mapping resulted in the first large-scale sequencing of
Xic subregions [63]. Several new genes and putative functional
elements within the Xic/XIC interval were identified. Amongst
them, the DXPas34 minisatellite lying 16 kb downstream of Xist
appeared to share significant properties with imprinting centres
governing the monoallelic expression of autosomal imprinted
clusters such as differential DNA methylation profiles [64] and
associated long-range non-coding transcription running antisense
to Xist [65]. The Xce locus was also shown to map to the Xic region
and to be distinct from Xist [66], although its precise location [67],
nature, and action remain undetermined.
The establishment of Xic physical maps and genomic sequenc-
ing also provided the tools to generate targeted mutations of
specific Xic elements and regions. Such mutagenesis notably
allowed the creation of a large deletion encompassing 65 kb of
sequence 39 to Xist, which resulted in a systematic inactivation of
the mutated X regardless of the presence of another X
chromosome in the cell [68]. At the time, this striking phenotype
was interpreted as identifying a counting element within the
deleted span, thereby irrevocably showing that Xist did not
recapitulate all Xic functions.
Main Discoveries since the Year 2000 and Pending
Questions (2000–Present)
During the new millennium, progress in gene targeting
facilitated the creation of a large variety of novel mutations within
the Xic that have considerably improved our understanding of X-
inactivation initiation. In parallel, the emergence of a role for
chromatin structures as putative transcription regulators [69,70]
and the development of Chromatin Immuno-Precipitation (ChIP)
techniques allowing analysis of chromatin composition [71] has
strongly impacted our ideas of the mechanisms involved in X-
inactivation, building in this respect on earlier documented
changes in Xi-associated global histone hypoacetylation [72] and
CpG island methylation [73,74]. These experiments have
underlined the likely integrated multi-level and redundant nature
of the mechanisms ensuring the stability of the inactive state.
Additionally, the finding that lineage specific genome programmes
could be efficiently reverted to the pluripotency state(s) as
demonstrated, notably, by female induced Pluripotent Stem (iPS)
cells [75] and that this was accompanied by Xi reactivation [76]
has reinforced interest in the link(s) between cell differentiation
and X-inactivation triggering suggested by ES cell differentiation
studies. Finally, the many studies of gene nuclear organisation that
have shown that chromatin fibres do not fold randomly but rather
in a dynamic and directed manner that is correlated with gene
expression status [77] have strongly encouraged the investigation
of these topological and dynamic aspects of X-inactivation
(Figure 3).
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In the mouse, the enigma of the transcription antisense to Xist
was resolved with the description of Tsix, a non-coding gene whose
major promoter is located just upstream of the DXPas34
minisatellite [78]. Interestingly, Tsix function does not seem to
be conserved in other species (see below). The targeted deletion of
Tsix [79–81] or of DXPas34 [82,83] induced a drastic reduction of
Tsix transcription that resulted in the preferential inactivation of
the mutated X in differentiated female cells. This indicated that
Tsix/DXPas34 is involved in the repression of Xist in pluripotent
ES cells and in random choice during differentiation [84,85]. The
implication of Tsix in imprinted X-inactivation has also been
inferred from the absence of apparent effect of paternally inherited
Tsix mutations as opposed to ectopic Xist expression and
embryonic lethality associated with maternal transmission
[80,86]. The role of Tsix in the counting process has been
addressed by targeting Tsix mutations to XO or XY cells. In the
majority of cases such mutations result in ectopic X-inactivation,
thereby pointing to a role of Tsix in the counting process
[68,81,82,85,87], although one report suggests otherwise [79].
Figure 2. Main discoveries of the years 1975 to 2000. (A) Timeline showing milestones in the history of X-inactivation (1975–2000). Images are
taken from http://commons.wikimedia.org, are a courtesy of the corresponding authors, or are unpublished data. (B) Map of the mouse Xic.
doi:10.1371/journal.pgen.1002212.g002
PLoS Genetics | www.plosgenetics.org 4 July 2011 | Volume 7 | Issue 7 | e1002212Figure 3. Main discoveries of the years 2000 to 2011. (A) Timeline showing milestones in the history of X-inactivation (2000–2011). Images are
taken from http://commons.wikimedia.org, are a courtesy of the corresponding authors, or are unpublished data. (B) Kinetics of events leading to
fully stable inactive state during the differentiation of female mouse ES cells.
doi:10.1371/journal.pgen.1002212.g003
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to be linked to variations in the differentiation protocols under use.
The emergence of regulatory antisense RNAs has raised a series
of questions as to their underlying mechanism(s) of action. Does it
necessarily involve RNA interference (RNAi) [88–90]? Or
RNApolII activity across the target genes? Or the induction of
local chromatin modifications? The investigation of these issues
has implicated Tsix transcription in maintaining an open
chromatin structure along the Xist gene [91–93] and in the setting
up of a specific chromatin configuration at the Xist promoter [94].
This activity does not appear to be critically dependent in Tsix
splicing [95]. Despite extensive community efforts, no conclusive
evidence for a role of siRNAs involving the Xist/Tsix overlap has
been adduced and the single report of such activity has yet to be
confirmed [96]. The absence of an RNAi-based mechanism as the
main mediator of Xist repression is in agreement with the absence
of a drastic X-inactivation phenotype in ES cells mutated for an
essential member of the RNAi machinery, Dicer [97,98].
In-Depth Characterisation of Xist Expression and the
Molecular Function(s) of Xist RNA
The fascinating visualisation of Xist/XIST RNAs ‘‘decorating’’
the Xi in cis but not in trans in a developmentally regulated manner
has prompted researchers to investigate the molecular mechanisms
behind Xist/XIST action. Keynote insights have come from a
series of experiments based on the use of inducible Xist cDNA
transgenes in male ES cells, a system that allowed the over-
expression of Xist at different time points during differentiation.
With the possible rider that these studies involve the generation of
non-physiological Xist expression levels and the use of Xist as a
spliced form, a major finding was that of a critical window of time
during which Xist was competent to induce transcriptional
repression and after which the chromosome becomes refractory
to silencing and the maintenance of gene repression is Xist
independent [99]. The existence of a ‘‘chromosomal memory’’
suggested by the observation of more efficient initiation of X-
inactivation in cells that had experienced earlier Xist exposure was
also postulated [99].
Using mutations within the Xist cDNA, the silencing function
was attributed to the highly conserved repeat A located at the 59
end of the transcript, whereas the rest of the molecule appears to
participate in the coating of the Xi in a synergistic, if partially
redundant, manner [100]. Another repeat (repeat C) also interacts
with a nuclear matrix attachment protein—hnRNP-U/SAF-A—
and this interaction is necessary for correct Xist coating [101].
These results may explain the long-standing observation that Xist
RNAs remained attached to the nuclear matrix after chromatin
extraction [58], suggesting that Xist transcripts interact with the
nuclear scaffold rather than directly with the Xi (for review see
[102,103]). Xist-mediated mechanism(s) might also involve—albeit
probably indirectly—the SATB1 and SATB2 nuclear matrix
attachment proteins [104–106].
Chromatin Modifications, Chromatin Remodellers, and
Their Role in the Establishment and Maintenance of
Silencing
In the noughtie years, multiple experiments were aimed at
indexing the chromatin modifications that characterise the Xi in
the hope of reconstructing the chain of events leading to the fully
locked inactive state. One of the strategies employed involved
using immuno-fluorescence combined with Xist RNA-FISH at
successive time points during female ES cell differentiation [107].
A sequential ordering was described with Xist coating of the Xi as
the trigger rapidly followed by RNApolII exclusion, the loss of
euchromatic marks and almost concomitantly the recruitment of
the Polycomb group complex PRC2 [108–111], then PRC1 [112]
with the consequent accumulation of the heterochromatin marks
H3K27me3 and H2AK119ub. Other heterochromatic marks,
histone variants such as macroH2A [113], chromatin remodellers
(ATRX) [114], and CpG island methylation were other later
apposed modifications (for details of the kinetics and the nature of
the modifications see [115]).
The number and variety of epigenetic changes—including those
still to be uncovered—highlights the extent and depth of the
progressive metamorphosis that the presumptive X undergoes
during X-inactivation. Although the regional organisation of these
different marks along the length of the Xi remains to be
established, some ChIP data have already revealed that some
marks such as H3K27me3 are preferentially associated with
promoters and gene bodies [116], and others, such as the
macroH2A histone variants, are more globally distributed [117].
Interestingly, whilst DNA methylation was observed at Xi gene
promoters—albeit quite heterogeneously—genes on the active X
were hypomethylated at the promoter and hypermethylated in the
body of the gene [118]. ChIP analyses on the Xic region have
suggested that the presence of specific chromatin domains along
the Tsix/Xist locus and upstream of Xist prior to the onset of
differentiation is important for X-inactivation randomness
[93,119,120], but stringent analysis of the specific function of the
individual epigenetic marks is still mostly lacking.
Revisiting the Kinetics of X-Inactivation during Pre-
Implantation Development
A fundamental question regarding the nature of the imprint on
X chromosomes has been to clarify whether the paternal X enters
the oocyte in an already ‘‘pre-inactivated’’ state that is subse-
quently maintained, implying that paternal genes would be silent
from the zygotic stage onwards. This question has been the theatre
of both lively debate and extensive work. RNA-FISH analysis of
several genes interspersed along the paternal X during pre-
implantation have now led to the consensual view that an
additional reactivation of the paternal X must occur at some point
between the onset of spermiogenesis and the 2- to 4-cell embryo
stage [121–123]. These analyses also revealed that genes on the
paternal X were not silenced synchronously, suggesting that the
initial repressive state involves genes or possibly region-specific
mechanisms.
The evidence of de novo imprinted X-inactivation during pre-
implantation development [111,124,125] favours the existence of
a robust imprint acting to prevent the inactivation of the maternal
X at these stages. This hypothesis is supported by previous
observations on gynogenetic embryos where the absence of
imprinted X-inactivation was accompanied by the death of the
embryos around implantation, in contrast to androgenetic
embryos, which were capable of achieving regular random X-
inactivation and of surviving until E7.7 [59]. This imprint could be
mediated by a strong repression of Xist (as illustrated by the total
lack of expression from the maternal Xist locus compared to a
pinpoint expression from the paternal locus [125]), although the
requirement of Xist for the triggering of imprinted X-inactivation
has recently been questioned [121].
Linking X-Inactivation to Pluripotency and Genome
Reprogramming
The long-searched-for link between cellular differentiation and
X-inactivation was recently established through the discovery
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intron 1 to prevent Xist upregulation in undifferentiated ES cells
[126] whilst the pluripotency factors Rex1, Klf4, and c-myc
occupied the Tsix promoter and activated Tsix expression [127].
As a consequence at the onset of differentiation, the loss of these
pluripotency factors would be expected to be associated with the
induction of Xist upregulation. Whilst it is clear that additional
binding sites of pluripotency factors/developmentally regulated
factors within the Xic remain to be uncovered [128], these
important results suggest a direct connection between Xi
reactivation during experimentally induced pluripotency and
the molecular mechanisms responsible for the genome-wide
resetting occurring in the inner cell mass (ICM) (for review see
[129,130]).
It is striking that Nanog has also been detected in female
Primordial Germ Cells (PGCs) from E7.75 onwards, a time when
Xi reactivation has been shown to initiate [131–133], indicating
that Nanog might also be involved in Xi reprogramming in the
female germline (for review see [134]). Intriguingly, however, Xi
reactivation appears to occur progressively throughout the time of
PGCs’ migration to the genital ridge, thereby dramatically
contrasting with the speed of reactivation occurring in the ICM.
This suggests that slightly different and as yet uncharacterised
mechanisms may be at work during one of the types of
reactivation. Another related question concerns the absence of
reactivation of the paternal Xi during early pre-implantation
despite the expression of some of the key pluripotency factors. An
attractive working hypothesis is that parental imprinting at these
stages prevents the action of the pluripotency factors. The lack of
Xi reactivation in the epiblast (and in derived female EpiStem
Cells [135]) raises similar issues, although at this later stage, the
absence of some pluripotency factors such as Nanog and Rex1
thought to be required for the initial Xist repression [126] may be
sufficient explanation.
Nuclear Dynamics and trans-Communication between
X-Chromosomes
Large-scale nuclear reorganisation has been shown to accom-
pany the establishment of random X-inactivation. 3D-FISH
analyses suggest that the core of the Xi chromosome territory is
constituted of non-genic sequences, including LINE-1 repeats that
provide the support for the initial coating by Xist RNAs [136].
This is followed by global chromatin changes and by the relocation
of genes to within the Xist repressive compartment [137]. These
observations favour another of Mary Lyon’s hypotheses, who
proposed, based on an enrichment of the X chromosome for
LINE-1 elements, that the latter serve as ‘‘way-stations’’ facilitating
the propagation of the inactivation signal [138,139].
Nuclear dynamics may also be implicated in X chromosome
counting and random choice. It has recently been observed
that the two X chromosomes come into close nuclear
proximity both before and at the very beginning of the
differentiation process and that these X-X pairing events [61]
involve two specific regions within the Xic, respectively: the
Xpr, located within the Xpct gene [140], and the DXPas34-Tsix-
Xite region [141,142], which has long been suspected of
participating in both counting and choice. Dynamic nuclear
contacts between these regions are thought to mediate the
trans-sensing of the two X chromosomes and to resolve through
the apposition of distinct modifications on each allele, resulting
in transient asymmetric Tsix expression [143]. This would then
provide a window of opportunity for monoallelic Xist
upregulation (for a review on nuclear organisation during
X-inactivation, see [144]).
Changing Our Attitudes: The Evolution of
X-Inactivation Mechanisms
X-inactivation in ‘‘ancient mammals’’ such as the marsupial is
characterised by unstable imprinted inactivation of the paternal X,
and, on this basis, imprinted X-inactivation was hypothesised until
the mid-1990s to represent the ancestral form of X-inactivation
[145]. This form of X-inactivation was thought to have been partly
conserved in the mouse, which displays imprinted X-inactivation
both during pre-implantation development, prior to the onset of
random X-inactivation [111,124,146], and in extra-embryonic
tissues [29], whereas hominids appear to have evolved towards the
complete replacement of imprinted by random X-inactivation
[147,148] (reviewed in [149]). Crucial insights into our under-
standing of the evolution of X-inactivation mechanisms have come
from recent sequence comparison of the X-inactivation centres of
different species [150,151]. These showed that Xist/XIST has
evolved from a protein coding gene present in marsupials,
indicating that other non-coding RNAs or totally different
mechanisms must be at work in such ‘‘ancient mammals’’ [152].
Xic/XIC sequence comparisons had previously shown that the
human TSIX was either completely absent or present in a
truncated form, resulting in an absence of antisense transcription
at the XIST promoter [150,153,154] (for review see also [155]). In
parallel, other studies have led to the identification of several new
non-coding genes (Jpx/Enox and Ftx) in the Xic, showing various
degree of conservation [150]. Taken together, these analyses
underline the surprising evolutionary instability of the master
region controlling X-inactivation and of some of the key actors
identified as critical in functional studies in the mouse.
Other important mechanistic differences have been identified
through transgenic experiments. For instance, a YAC transgene
containing the entire human XIST when integrated into the mouse
genome, unlike the endogenous mouse Xist gene, initiated X-
inactivation even before differentiation [156,157]. This points to a
conservation—totally or partially—of the mechanisms involved in
the cis-spreading of X-inactivation between the two species
together with a lack of conservation of the mechanisms acting to
ensure XIST cis-repression prior to differentiation. The latter may
be associated with the absence of human TSIX (see above).
Interestingly, a recent comparison of X-inactivation profiles
during pre-implantation development in humans and rabbits has
found a late onset of X-inactivation in both species compared to
mice and initial biallelic upregulation of Xist alleles prior to
monoallelic resolution [158]. Additional species-specific differenc-
es include the recruitment of diverse heterochromatin marks in
marsupials, mice, and humans [159–162].
A last but certainly not least difference between mice and
human concerns X-linked genes escaping from X-inactivation. In
humans, unlike mice [163], a large number (15%) of X-linked
genes have been shown to escape from X-inactivation [164],
offering a potential explanation of the severity of the phenotypic
alterations observed in XO women (Turner Syndrome) compared
to mice (for review see [165,166]). A level of variability in the
degree of escape has also been reported between individuals,
between tissues, and even amongst cells of the same tissue.
Interestingly, the distribution of the genes escaping from X-
inactivation along the chromosome also differs between human
and mouse. In mice, the few ‘‘escapees’’ are either embedded
within regions undergoing X-inactivation or located within the
single murine Pseudo-Autosomal Region (PAR) (shared with the Y
chromosome). In humans, genes escaping from X-inactivation are
similarly found in both human PARs but, in addition, exist within
clusters in large genomic domains that may be several megabases
PLoS Genetics | www.plosgenetics.org 7 July 2011 | Volume 7 | Issue 7 | e1002212in size. This suggests that large-scale chromatin remodelling as
opposed to gene-based mechanisms is likely at work in humans
[163,164,167]. In mice, LINE-1 transcription [136], the expres-
sion of other non-coding RNAs [168], and binding of the insulator
CTCF [169] at the boundaries of escapees are associated with the
looping out from the Xist-repressive compartment [137], which is
thought to participate in preventing the spreading of heterochro-
matin into genes that escape from X-inactivation. Transgenesis
approaches allowing the introduction of escapees into different
genomic contexts should enable the further dissection of the
molecular mechanisms underlying this phenomenon [170].
An unexpectedly large variety of mechanisms involved in the
initiation, spreading, and stabilisation of X-inactivation therefore
probably exist in the mammalian kingdom. This suggests that ‘‘a la
carte’’ mechanisms most likely evolved to adapt to, and cope with,
the developmental and gestational specificities of each species. The
original observation of the dense Barr body led researchers to
postulate a chromosome-wide process that would affect the entire
X chromosome uniformly. The more recent findings suggest that
gene- or gene cluster-based mechanisms allow the fine tuning of
X-inactivation to cope with the specific requirements of develop-
ment and/or tissue/lineage functionalities. Such mechanisms may
be related to systems used in other phyla to compensate sex
chromosome dosage, as in birds, where only few genes are subject
to dosage compensation [171,172], or in Drosophila, where X over-
expression in males is initially established preferentially and locally
at entry sites scattered all along the X [173].
Concluding Remarks
As the inactivation traveller looks back over the 50 years since
Mary Lyon’s original hypothesis was published, it seems that quite
a long—if winding—road has been covered and some great
achievements made. Raising our eyes, however, reveals the extent
of the path still in front of us.
Moreover, earlier X-inactivation travellers, like Himalayan
climbers, have left their load of unresolved issues. For instance,
despite intense scrutiny and in-depth mutagenesis studies, we still
mostly ignore how the XIC/Xic exerts its function, and even Xist’s
mode of action remains rather obscure. A role for Xist in recruiting
the chromatin remodeller PRC2 [174], which, in turn, triggers
H3K27 trimethylation, has found support from similar results
obtained with other large non-coding RNAs such as Air/AIR,
Kcnq1ot1/KCNQ1OT1 (regulation of imprinted genes at the Igf2r/
IGF2R and at the Cdkn1c/CDKN1C loci), and HOTAIR (develop-
mental regulation of HOXD gene cluster in human) [175,176]. The
recent observation that the mutation of the mouse Hotair was
without dramatic impact on the regulation of the mouse Hoxd
cluster [177] provides a welcome cautionary reminder of the need
to cross-reference such studies to in vivo functional approaches. We
also still ignore how the original euchromatic marks are removed
from the Xi. Does this require the association of Xist RNAs with
specific histone demethylases, or does it depend solely on the
passive dilution occurring via DNA replication and/or successive
mitoses? Other Xist/XIST-related questions concern the potential
role of Xist/XIST splice variants—are they just relics of evolution?
Or integral to the resetting of the Xist/XIST domain after DNA
replication or mitosis?
Within the Xic, the function of many of the more recently
discovered non-coding RNAs such as Jpx/Enox [178,179] and Ftx
[180] and of sites of intergenic transcription such as Xite [181] and
the Region B [150] remains to be fully elucidated, as does the role of
actors lying outside of the immediate Xic/XIC interval, which are
involved in the counting process. The U3 ubiquitin ligase
produced by the X-linked Rnf12 gene, which was recently shown
to act on the initiation of X-inactivation in a dose-dependent
manner, is the first of such actors to be characterised [182–184].
The concentration of research into understanding how the Xic/
XIC operates to count, choose, and initiate X-inactivation has led
to a relative neglect of other topics such as that concerning the re-
equilibration of levels of expression between the single Xa and
autosome pairs. The latter has been suggested to involve the global
upregulation of genes on the Xa in both males and females,
inducing an increase of 1.4- to 2-fold in expression levels of the X
chromosome during the time course of differentiation [185,186],
although a later study involving high-throughput RNA sequencing
failed to confirm these observations [187]. Clarification of this
important point and a more detailed understanding of the
underlying mechanisms are likely to impact largely on current
models of both dosage compensation and of the evolution of the
sex chromosomes.
The molecular processes responsible for the individualisation of
the establishment of a heterochromatin structure on a gene-by-
gene basis and the nature of the mechanism(s) rendering
‘‘escapees’’ resistant to global heterochromatinisation or sensitive
to reactivation similarly remain, for the most part, unknown. Some
of these studies will clearly benefit from the single-cell analyses that
will be required to follow in real time the chromatin dynamics
occurring during embryogenesis and to capture the putative
furtive nuclear interactions and changes in large-scale chromatin
organisation that are likely to be part and parcel of the initiation of
X-inactivation. Clearly, integrating chromosome-wide and Xic
nuclear dynamics to transcriptional regulation is but one step in
this process. The development of in vivo systems allowing the
specific perturbation of some of these features/mechanisms during
early embryogenesis will, almost certainly, be critical to a complete
understanding of how a fully stable Xi is established and how Xi
and Xa epigenetic features are transmitted during the formation of
mosaic cell populations making up the pre-implantation embryo.
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